Commentary: an important step forward in the treatment of SVC syndrome: rapid relief of symptoms using the Trellis system.
Morrissey
Nicholas J
NJ
Division of Vascular Surgery, Columbia/Weill Cornell, New York Presbyterian Hospital, 161 Ft Washington Ave, Suite 639, New York, NY 10032, USA. njm2106@columbia.edu
D000800:Angioplasty, Balloon / Q000295:instrumentation; D000925:Anticoagulants / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003251:Constriction, Pathologic; D004487:Edema / Q000209:etiology / Q000628:therapy; D004867:Equipment Design; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D012008:Recurrence; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D017131:Thrombectomy / Q000295:instrumentation*; D015912:Thrombolytic Therapy / Q000295:instrumentation*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome; D014654:Vascular Patency
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010959:Tissue Plasminogen Activator